Drug name - Naloxone Hydrochloride (autoinjector)

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8425462 KALEO INC Devices, systems, and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US8313466 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US8361029 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US10737028 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US9737669 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US7918823 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US9056170 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US8608698 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US10314977 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(1 year, 11 months from now)

US7731690 KALEO INC Devices, systems and methods for medicament delivery
Jan, 2025

(2 years from now)

US8016788 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2025

(2 years from now)

US10335549 KALEO INC Devices, systems and methods for medicament delivery
Apr, 2025

(2 years from now)

US7947017 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2028

(5 years from now)

US9022022 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US9474869 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US9814838 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US10322239 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US8939943 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Feb, 2031

(8 years from now)

US10143792 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone
May, 2031

(8 years from now)

Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient

Market Authorisation Date: 28 February, 2022

Treatment: Use of a delivery device to administer a dose of naloxone; Use of a delivery device to deliver a dose of naloxone

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
10MG/0.4ML (10MG/0.4ML) SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in